Natalia Jura

Co-Founder at Rezo Therapeutics

Natalia Jura, Ph.D., is a Co-Founder of Rezo. She is also a Professor at the Department of Cellular and Molecular Pharmacology and Investigator at the Cardiovascular Research Institute at the University of California, San Francisco (UCSF). Natalia’s group applies X-ray crystallography and cryo-EM to investigate mechanisms of receptor tyrosine kinase signaling, and non-canonical functions of atypical protein kinases, called pseudokinases. In addition to her research activities at UCSF, Natalia serves as an Associate Director of the Quantitative Biosciences Institute (QBI) at UCSF. Natalia was recently awarded a UCSF Byers Award and 2020 Women in Biochemistry and Molecular Biology Leadership Award from the American Society for Biochemistry and Molecular Biology. Natalia received an M.S. in Biochemistry from Jagiellonian University in Krakow, Poland and a Ph.D. in Molecular and Cellular Biology from Stony Brook University followed by postdoctoral training in structural biology at University of California, Berkeley.